Cardiac arrhythmias in patients with acute myocardial ischemia, which developed on the background of comorbid hypertension and diabetes

  • Received 10.12.2020

  • Revised 25.01.2021

  • Accepted 23.02.2021



  • 830 Views

  • Retrieved from Volume 3, No. 1, 2021

  • Pages 5-9

Summary. Acute coronary syndrome (ACS) is one of the leading causes of deaths in the world. The development of acute myocardial ischemia is accompanied by cardiac arrhythmias (CА), especially in conditions of comorbidity. In most patients (up to 80 %) MI develops on the background of arterial hypertension (AH), and in 50 % – diabetes mellitus (DM). The aim of the study – to compare current scientific data on arrhythmias in the acute period of myocardial infarction on the background of hypertension and diabetes and compare them with the data of own studies. Materials and Methods. Data from 2145 patients aged 29–89 years, mean age (65.10±0.37) years, men – 70.57 %, women – 29.43 % were selected for the study, who were divided into 4 groups: group 1 (n = 1061) – patients with MI and concomitant hypertension without diabetes (MI + hypertension without diabetes), group 2 (n = 400) included patients with MI and concomitant hypertension and diabetes (MI + hyperten-sion + diabetes), group 3 ( n = 355) – patients with MI with-out hypertension and diabetes, group 4 (n = 329) – patients with MI without concomitant pathology. With the help of the licensed program SPSS v.21 statistical processing of data en-tered in spreadsheets Excel – 2010. Results. In our study, significant СА in the acute period were manifested by supraventricular (9.8 %) and ventricular (18.7 %) extrasystoles, paroxysms of supraventricular (1.4 %) and ventricular (5 %) tachycardia, ventricular fibrillation (2.9 %), paroxysms of atrial fibrillation (9 %), and in 6.3 % of MI developed on the background of chronic atrial fibrillation. Violation of atrioventricular conduction degree I–III was recorded in 4.6–2.2 %, on the His bundle – in 7.2 % on the right leg, in 5 % – on the left leg. Most СА were observed in patients with MI and concomitant hypertension and diabetes. Ventricular arrhythmias were observed in patients with-out concomitant hypertension and diabetes. Chronic atrial fibrillation was prevalent in patients without concomitant diabetes. Conclusions. Comorbid pathology, in particular hypertension and diabetes, enhances the proarrhythmogenic potential of the myocardium in acute ischemia and worsens the early and long-term prognosis after MI, which requires optimization of management of such patients

myocardial infarction, cardiac arrhythmia, arterial hypertension, diabetes mellitus

https://doi.org/10.11603/bmbr.2706-6290.2021.1.11789

[1] Nascimento  BR,  Brant  LCC,  Marino  BCA,  Passa-glia  LG,  Ribeiro ALP.  Implementing  myocardial  infarction systems  of  care  in  low/middle  income  countries.  Heart. 2019;105: 20-6. DOI: 10.1136/heartjnl-2018-313398.

[2] Belik BE, Gruzdeva OV, Karetnikova VN. [Glycemia on admission and the characteristics of the hospital period in  patients  with  ST-segment  elevation  myocardial  infarc-tion]. Sibirskiy meditsinskiy zhurnal. 2014;4: 25-8. Russian.

[3] Heidbüchel H, Tack J, Vanneste L, Ballet A, Ector H, Van de Werf F. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with al-teplase and effect of early administration of a beta-blocker or  a  bradycardiac  agent  on  their  incidence.  Circulation. 1994;89(3): 1051-9. DOI: 10.1161/01.cir.89.3.1051.

[4] Mont L, Cinca J, Blanch P, Blanco J, Figueras J, Bro-tons C, et al. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase  of  acute  myocardial  infarction.  J Am  Coll  Cardiol. 1996;(7): 1670-6. DOI: 10.1016/S0735-1097(96)00383-X.

[5] Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients re-ceiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation. 1998;8;98(23): 2567-73. DOI: 10.1161/01.cir.98.23.2567.

[6] Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, et al. Long-term recording of cardiac arrhythmias with an implantable car-diac monitor in patients with reduced ejection fraction after acute  myocardial  infarction:  the  Cardiac Arrhythmias  and Risk  Stratification  After  Acute  Myocardial  Infarction  (CA-RISMA) study. Circulation. 2010 Sep 28;122(13): 1258-64. DOI: 10.1161/CIRCULATIONAHA.109.902148.

[7] Gorenje  B,  Blomstrom  Lundqvist  C,  Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from  the  joint  EHRA, ACCA,  and  EAPCI  task  force.  EP Europace. 2014;16: 1655-73. DOI:10.4244/EIJY14M08_19.

[8] Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston  SA  et  al.  Atrial  fibrillation  and  death  after myocardial infarction. Circulation. 2011;123(19): 2094-100. DOI: 10.1161/CIRCULATIONAHA.110.990192.

[9] Demidova MM, Smith JG, Höijer C-J, Holmqvist F, Erlinge D, Platonov PG. Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated  with  primary  PCI.  Eur  Heart  J Acute  Cardiovasc Care. 2012;1: 302-11. DOI: 10.1177/2048872612463553.

[10] Grebenyk  MV,  Dovhalyuk  MP,  Masliy  SM,  Zele-nenka  LI,  Badyuk  NV.  [Myocardial  infarction  and  cardiac arrhythmias according to the local registry]. Ukrainskyi kar-diolohichnyi zhurnal. 2018;1: 77-8. Ukrainian.